Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Update on acute leukemia of ambiguous lineage in 2023 - Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)].
Simonin M, Lainey E, Rialland F, Caye-Eude A, Reguerre Y, Boutroux H, Azarnoush S, Thouvenin S, Rohrlich PS, Baruchel A. Simonin M, et al. Among authors: lainey e. Bull Cancer. 2023 Oct 27:S0007-4551(23)00383-1. doi: 10.1016/j.bulcan.2023.09.004. Online ahead of print. Bull Cancer. 2023. PMID: 39492072 Review. French.
CD36 cell surface expression as a surrogate marker to identify ABL/JAK-class kinase fusions in pediatric BCP-ALL.
Strullu M, Caye-Eude A, Robert E, Renard JM, Chaye A, Galimand J, Fenneteau O, Arfeuille C, Cuccuini W, Theron A, Thouvenin S, Paillard C, Petit A, Rohrlich PS, Cavé H, Baruchel A, Lainey E. Strullu M, et al. Among authors: lainey e. Leukemia. 2025 Jan;39(1):64-74. doi: 10.1038/s41375-024-02421-5. Epub 2024 Oct 17. Leukemia. 2025. PMID: 39420220
Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia.
Niswander LM, Loftus JP, Lainey É, Caye-Eude A, Pondrom M, Hottman DA, Iacobucci I, Mullighan CG, Jain N, Konopleva M, Cavé H, Baruchel A, Rohrlich PS, Tasian SK. Niswander LM, et al. Among authors: lainey e. Haematologica. 2021 Oct 1;106(10):2763-2767. doi: 10.3324/haematol.2021.278697. Haematologica. 2021. PMID: 34196168 Free PMC article. No abstract available.
Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia.
Brethon B, Lainey E, Caye-Eude A, Grain A, Fenneteau O, Yakouben K, Roupret-Serzec J, Le Mouel L, Cavé H, Baruchel A. Brethon B, et al. Among authors: lainey e. Front Oncol. 2021 Feb 26;11:637951. doi: 10.3389/fonc.2021.637951. eCollection 2021. Front Oncol. 2021. PMID: 33718232 Free PMC article.
A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Meyran D, Arfeuille C, Chevret S, Neven Q, Caye-Eude A, Lainey E, Petit A, Rialland F, Michel G, Plantaz D, Jubert C, Theron A, Gandemer V, Ouachée-Chardin M, Paillard C, Bruno B, Buchbinder N, Pochon C, Calvo C, Fahd M, Baruchel A, Cavé H, Dalle JH, Strullu M. Meyran D, et al. Among authors: lainey e. Haematologica. 2024 Sep 1;109(9):2908-2919. doi: 10.3324/haematol.2023.284103. Haematologica. 2024. PMID: 38385260 Free PMC article.
Success of donor-derived CAR-T cells after failure of autologous CD19 CAR-T cells (tisagenlecleucel) in B-cell acute lymphoblastic leukaemia.
Dourthe ME, Yakouben K, David A, Thouvenin S, Chaillou D, Caillat-Zucman S, Cuffel A, Tardy C, Lainey E, Caye-Eude A, Arfeuille C, Delaugerre C, Chaix-Baudier ML, Naudin J, Auvin S, Bergaoui K, Merlat-Guitard AI, De Jorna R, Mebarki M, Dalle JH, Baruchel A. Dourthe ME, et al. Among authors: lainey e. Br J Haematol. 2024 Jul;205(1):373-377. doi: 10.1111/bjh.19524. Epub 2024 May 12. Br J Haematol. 2024. PMID: 38735758 No abstract available.
Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia.
Dourthe ME, Rabian F, Yakouben K, Chevillon F, Cabannes-Hamy A, Méchinaud F, Grain A, Chaillou D, Rahal I, Caillat-Zucman S, Lesprit E, Naudin J, Roupret-Serzec J, Parquet N, Brignier A, Guérin-El Khourouj V, Lainey E, Caye-Eude A, Cavé H, Clappier E, Mathis S, Azoulay E, Dalle JH, Dhédin N, Madelaine I, Larghero J, Boissel N, Baruchel A. Dourthe ME, et al. Among authors: lainey e. Leukemia. 2021 Dec;35(12):3383-3393. doi: 10.1038/s41375-021-01281-7. Epub 2021 May 17. Leukemia. 2021. PMID: 34002027
Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network.
Caye A, Strullu M, Guidez F, Cassinat B, Gazal S, Fenneteau O, Lainey E, Nouri K, Nakhaei-Rad S, Dvorsky R, Lachenaud J, Pereira S, Vivent J, Verger E, Vidaud D, Galambrun C, Picard C, Petit A, Contet A, Poirée M, Sirvent N, Méchinaud F, Adjaoud D, Paillard C, Nelken B, Reguerre Y, Bertrand Y, Häussinger D, Dalle JH, Ahmadian MR, Baruchel A, Chomienne C, Cavé H. Caye A, et al. Among authors: lainey e. Nat Genet. 2015 Nov;47(11):1334-40. doi: 10.1038/ng.3420. Epub 2015 Oct 12. Nat Genet. 2015. PMID: 26457648
71 results